|
Bioprocess 2024
中草药通过调节微生态缓解结肠炎的研究进展
|
Abstract:
传统疗法治疗结肠炎存在局限性,迫切需要新方法。肠道菌群失调可以导致结肠炎,通过改善肠道菌群来治疗结肠炎是一种潜在的治疗方法。然而我们发现,现阶段大多数中药通过肠道菌群治疗结肠炎的研究都存在一定的局限性,治疗的机制不够明确,需要进一步的研究。针对这些不足,我们可以通过网络药理学、分子对接和实验验证等手段,挖掘调节肠道微生态缓解结肠炎的具体活性成分、作用靶点及其作用机理,为治疗结肠炎、研制新药物提供新思路。
Traditional therapies for colitis have limitations, and new methods are urgently needed. Dysbiosis of intestinal flora can lead to colitis, and the treatment of colitis by improving intestinal flora is a potential treatment. However, we found that at present, most studies on the treatment of colitis by intestinal flora in traditional Chinese medicine have certain limitations, and the mechanism of treatment is not clear enough, which needs further research. In view of these shortcomings, we can use network pharmacology, molecular docking and experimental verification to excavate the specific active components, targets and mechanisms of action of regulating intestinal microecology to relieve colitis, so as to provide new ideas for the treatment of colitis and the development of new drugs.
[1] | AlHussaini, K.I. (2023) Microscopic Colitis: A Review Article. Cureus, 15, e47150. https://doi.org/10.7759/cureus.47150 |
[2] | Hu, S., Zhao, R., Xu, Y., Gu, Z., Zhu, B. and Hu, J. (2024) Orally-Administered Nanomedicine Systems Targeting Colon Inflammation for the Treatment of Inflammatory Bowel Disease: Latest Advances. Journal of Materials Chemistry B, 12, 13-38. https://doi.org/10.1039/d3tb02302h |
[3] | Hung, T. H., Wang, C. Y. and Lee, H. F. (2023) Update in Diagnosis and Management of Irritable Bowel Syndrome. Tzu Chi Medical Journal, 35, 306-311. https://doi.org/10.4103/tcmj.tcmj_104_23 |
[4] | Loveikyte, R., Bourgonje, A.R., van Goor, H., Dijkstra, G. and van der Meulen-de Jong, A.E. (2023) The Effect of Iron Therapy on Oxidative Stress and Intestinal Microbiota in Inflammatory Bowel Diseases: A Review on the Conundrum. Redox Biology, 68, Article ID: 102950. https://doi.org/10.1016/j.redox.2023.102950 |
[5] | Schirmer, M., Garner, A., Vlamakis, H. and Xavier, R.J. (2019) Microbial Genes and Pathways in Inflammatory Bowel Disease. Nature Reviews Microbiology, 17, 497-511. https://doi.org/10.1038/s41579-019-0213-6 |
[6] | Lloyd-Price, J., Arze, C., Ananthakrishnan, A.N., Schirmer, M., Avila-Pacheco, J., Poon, T.W., et al. (2019) Multi-Omics of the Gut Microbial Ecosystem in Inflammatory Bowel Diseases. Nature, 569, 655-662. https://doi.org/10.1038/s41586-019-1237-9 |
[7] | Roy, S. and Dhaneshwar, S. (2023) Role of Prebiotics, Probiotics, and Synbiotics in Management of Inflammatory Bowel Disease: Current Perspectives. World Journal of Gastroenterology, 29, 2078-2100. https://doi.org/10.3748/wjg.v29.i14.2078 |
[8] | Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., Sánchez, B. and Margolles, A. (2017) Bifidobacteria and Their Health-Promoting Effects. Microbiology Spectrum, 5. https://doi.org/10.1128/microbiolspec.bad-0010-2016 |
[9] | Li, M.Y., Luo, H.J., Wu, X., Liu, Y.H., Gan, Y.X., Xu, N., Zhang, Y.M., Zhang, S.H., Zhou, C.L., Su, Z.R., Huang, X.Q., and Zheng, X.B. (2020) Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways. Frontiers in Pharmacology, 10, Article 1552. https://doi.org/10.3389/fphar.2019.01552 |
[10] | Luo, S., Wen, R., Wang, Q., Zhao, Z., Nong, F., Fu, Y., Huang, S., Chen, J., Zhou, L. and Luo, X. (2019) Rhubarb Peony Decoction Ameliorates Ulcerative Colitis in Mice by Regulating Gut Microbiota to Restoring Th17/Treg Balance. Journal of Ethnopharmacology, 231, 39-49. https://doi.org/10.1016/j.jep.2018.08.033 |
[11] | Yuan, Z., Yang, L., Zhang, X., Ji, P. and Wei, Y. (2020) Therapeutic Effect of N-Butanol Fraction of Huang-Lian-Jie-Du Decoction on Ulcerative Colitis and Its Regulation on Intestinal Flora in Colitis Mice. Biomedicine & Pharmacotherapy, 121, Article ID: 109638. https://doi.org/10.1016/j.biopha.2019.109638 |
[12] | Liu, Y., Li, B.G., Su, Y.H., Zhao, R.X., Song, P., Li, H., Cui, X.H., Gao, H.M., Zhai, R.X., Fu, X.J. and Ren, X. (2022) Potential Activity of Traditional Chinese Medicine against Ulcerative Colitis: A Review. Journal of Ethnopharmacology, 289, Article ID: 115084. https://doi.org/10.1016/j.jep.2022.115084 |
[13] | Zhang, B., Liu, K., Yang, H., Jin, Z., Ding, Q. and Zhao, L. (2022) Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples. Frontiers in Cellular and Infection Microbiology, 12, Article 855075. https://doi.org/10.3389/fcimb.2022.855075 |
[14] | Nogales, C., Mamdouh, Z.M., List, M., Kiel, C., Casas, A.I. and Schmidt, H.H.H.W. (2022) Network Pharmacology: Curing Causal Mechanisms Instead of Treating Symptoms. Trends in Pharmacological Sciences, 43, 136-150. https://doi.org/10.1016/j.tips.2021.11.004 |